Department of Applied Statistics and Data Science (DASDS), PSPH and Novo Nordisk organised ‘Online Workshop Series - Industry Perspectives on AI and Data Analytics in Healthcare and Pharma’ from April 16, 2026, to May 07, 2026, through Microsoft Teams.

Session 1: Digital Health: Current Trends and Future Technologies.

This session conducted by Shruthi Vidyasagar (Novo Nordisk) on April 16, 2026 (14:00 to 15:00 IST) covered the evolving landscape of digital health, specifically focusing on building an ecosystem that extends "beyond the pill" through integrated technology. Students learned how tools like dose-calculating apps, connected devices, and wearables are being utilized to create a more personalized and data-driven patient experience.

Session 2: Analytics Consulting in Healthcare & Life Sciences.

Led by industry leader Raj Dave (Novo Nordisk), this session held on April 16, 2026 (15:00 to 16:00 IST) detailed the fast-paced career trajectories available within healthcare analytics consulting. The presentation highlighted how professionals evolve from junior roles focused on deep functional expertise to senior leadership positions managing complex client value chains and business units.

Session 3: FAIR Data Management Practices in Pharma R&D and AI Adoption.

Dr Sandhya Balaji Iyer (Novo Nordisk) introduced the "FAIR" principles—ensuring data is Findable, Accessible, Interoperable, and Reusable—as the backbone of modern pharmaceutical R&D. The session held on April 24, 2026 (14:00 to 15:00 IST) emphasized that these rigorous data management practices are essential prerequisites for the successful and ethical adoption of AI in the life sciences.

Session 4: Digital Trends, Innovation and Data Analytics in Pharma Landscape (From Insights to Impact: Navigating the Landscape of Data Analytics and Applied Data Science in Pharma).

This session conducted by Rashmi Jain (Novo Nordisk) on April 30, 2026 (14:00 to 15:00 IST) focused on the critical role of clinical study endpoints, stressing that trial success depends on decisions designed in advance rather than just post-hoc analysis. It also provided a strategic Career Growth Plan for students, urging them to strengthen their soft skills and "web literacy" regarding the clinical trial ecosystem to stay competitive.

Session 5: Future of Healthcare Analytics: A Deep Dive into AI-Enhanced Analytics, Reporting Evolution, and Workflow Automation.

Conducted by Ashutosh Gaur (Novo Nordisk), this session on May 07, 2026 (14:00 to 15:00 IST) explored the technological shifts redefining how data is processed and presented in the healthcare sector. The discussion centered on the evolution of reporting, moving from static data displays to dynamic, AI-enhanced analytics that provide deeper, predictive insights. The session underscored that the future of analytics lies in creating seamless, automated pipelines that transform raw data into actionable healthcare intelligence.

Session 6: Adoption of Generative AI tools and Technologies in Pharma Sector.

Led by Bhargavi Mahadevappa (Novo Nordisk), this session on May 07, 2026 (15:00 to 16:00 IST) delved into the transformative potential of Generative AI within the pharmaceutical industry. The presentation covered how GenAI tools are being adopted to accelerate drug discovery, optimize clinical trial documentation, and personalize medical communications.